Welcome to our dedicated page for ENSIGN GROUP SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (ENSG) filings document its public-company reporting as a Delaware healthcare services company with common stock listed on the Nasdaq Global Select Market. Its disclosures cover skilled nursing and senior living operations, therapy and rehabilitative services, healthcare real estate, and the Standard Bearer real estate segment.
Ensign’s 8-K reports disclose quarterly and annual operating results and Regulation G non-GAAP measures, including adjusted net income, adjusted earnings per share, EBITDA, adjusted EBITDA, adjusted EBITDAR, adjusted EBT, and Funds from Operations for its real estate segment. Proxy materials cover shareholder voting, board governance, executive compensation, equity awards, capital-structure matters, and other governance disclosures.
Baillie Gifford & Co has filed a Schedule 13G reporting beneficial ownership of 4,569,254 shares of Ensign Group, Inc. common stock, or about 7.89% of the class, as of December 31, 2025.
Baillie Gifford reports sole voting power over 3,924,777 shares and sole dispositive power over all 4,569,254 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course of business on behalf of investment advisory clients and not for the purpose of changing or influencing control of Ensign Group.
A holder of ENSG common stock filed a notice to sell 375 shares under Rule 144. The shares were acquired through restricted stock vesting on 07/15/2021 as compensation from the issuer. The planned sale, via Fidelity Brokerage Services on NASDAQ, has an aggregate market value of 74250.00 based on the filing. The issuer had 58,112,780 shares outstanding when this notice was prepared.
A shareholder has filed a notice of proposed sale of 100 shares of common stock under Rule 144. The shares are planned to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 02/09/2026 and an aggregate market value of $19,800.00.
The 100 shares were acquired from the issuer on 01/15/2026 through restricted stock vesting as compensation, with payment also dated 01/15/2026. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.
A shareholder filed a notice of intent to sell 4,573 shares of common stock through Fidelity Brokerage Services on NASDAQ, with an aggregate market value of 896,823.73.
The shares come from recent option exercises: 2,268 shares acquired on 02/06/2026 from an option granted on 08/31/2016, and 2,305 shares acquired on 02/05/2026 from an option granted on 05/25/2017, both paid in cash.
During the past three months, Suzanne Snapper sold 8,258 common shares on 02/05/2026 for gross proceeds of 1,606,055.89, as disclosed in the same notice.
An affiliated holder of ENSG has filed a notice of proposed sale of restricted securities. The filing covers 8,258 common shares, with an aggregate market value of $1,606,055.64, to be sold on or about 02/05/2026 on the NASDAQ through Fidelity Brokerage Services.
The shares consist of 4,129 shares from stock options granted on 08/31/2016 and 4,129 shares from options granted on 05/25/2017, all acquired and paid for in cash on 02/05/2026. The seller represents they are not aware of any undisclosed material adverse information about ENSG’s current or prospective operations.
Ensign Group director Barry M. Smith reported a planned sale of company stock. On February 2, 2026, he sold 700 shares of common stock at $171.54 per share in an open-market transaction. The trade was made under a Rule 10b5-1 trading plan adopted on July 29, 2025, indicating it was pre-arranged. After this sale, he beneficially owns 23,552 shares of Ensign Group common stock directly.
The Ensign Group, Inc. filed a current report to note that it issued a press release with its financial results for the fourth quarter and year ended December 31, 2025. The press release is furnished as Exhibit 99.1.
The company highlights several non-GAAP measures used in that release, including Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations for its real estate segment. The filing explains how each metric is calculated from net income and why management believes these measures provide supplemental insight, while emphasizing they should be considered alongside GAAP results and may not be comparable to similar measures used by other companies.
The Ensign Group, Inc. is a holding company that provides skilled nursing, senior living, rehabilitation and ancillary services through independent subsidiaries in 17 states. As of December 31, 2025, it operated 373 skilled nursing and senior living facilities with 37,911 operational skilled nursing beds and 3,402 senior living units.
About 95.6% of 2025 revenue came from skilled nursing facilities, with the remainder from real estate, senior living and ancillary services. Ensign also owns 158 healthcare properties and operates a captive REIT, Standard Bearer, which holds 152 properties and generated $126.9 million of rental revenue in 2025.
Medicaid and Medicare are the largest payors, representing 46.6% and 24.7% of 2025 skilled services revenue. The company has grown through acquisitions, adding 145 facilities since 2021, and focuses on high‑acuity patients, local leadership, and value‑based care. The filing details extensive regulatory and reimbursement risks across Medicare, Medicaid and emerging value‑based payment models.
Barry M. Smith has filed a notice under Rule 144 to sell 700 shares of common stock through Fidelity Brokerage Services LLC on or about 02/02/2026 on the NASDAQ, with an aggregate market value of $120,078.00. The issuer had 57,924,783 shares of this class outstanding.
The shares to be sold were acquired through restricted stock vesting compensation transactions between 01/15/2024 and 01/17/2025. Over the prior three months, Smith sold 700 shares of common stock on each of three dates, with gross proceeds of $126,448.00, $128,989.00, and $121,513.00.
Ensign Group director John O. Agwunobi reported small, pre-planned stock sales. On January 20, 2026, he sold 246 shares of Ensign Group common stock at an average price of $179.82 per share. On January 21, 2026, he sold an additional 146 shares at an average price of $178.31 per share, for a total of 392 shares sold.
After these transactions, he beneficially owned 9,087.149 Ensign Group shares in direct form. The filing states these sales were executed under a Rule 10b5-1 trading plan adopted on July 31, 2025, which is a pre-arranged program allowing insiders to sell shares according to preset instructions.